TFRC and neoplasm: Brain-targeting nanoparticles that engage transferrin receptors or utilize RVG29/angiopep-2 peptides can ferry cargo across the BBB, co-delivering cytotoxics and immune adjuvants to both tumor cells and TAMs, thereby coordinating direct tumor kill with myeloid reprogramming (39, 40).